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1. Introduction 
A well established and widely accepted concept is 
the activation of adenylate cyclase as a consequence of
the interference of hormones with the plasma 
membrane. The concomittant increase of cyclic AMP, 
the second messenger, results in an increase of 
metabolic activity of the cell. Little is however known 
about the metabolic ontrol of this activation. 
Some agents of possible physiological significance 
on the adenylate cyclase activity has been studied. For 
example Ca ~ [1], guanine nucleotides [2,3] and 
adenosine [4] have been demonstrated to have an 
effect on the enzyme activity, and may be of 
importance for its physiological regulation in the cell. 
In the present paper we want to stress the importance 
of the oxidation-reduction state as a possible regulator 
of the adenylate cyclase activity and demonstrate he 
inhibitory effect of reduced nicotine amide adenine 
dinucleotide on the adenylate cyclase activity in 
isolated adipocyte plasma membranes. 
phosphate and 1 mg/ml creatine kinase. The incubation 
was initiated by the addition of the membrane prepara- 
tion in a volume of 10/al to each incubation tube, the 
final volume being 50 tal. Protein was determined 
according to Lowry et al. [8]. Nucleotides and other 
finechemicals were from Sigma Co, St Louis, USA, 
isotopes from New England Nuclear GmbH, Langen, 
Germany, noradrenaline bitartrate was from ASTRA 
AB, S6dert/ilje, Sweden, and 1-24 ACTH from Ciba, 
Basel, Switzerland. Other reagents used were of 
analytical grade. 
3. Results and discussion 
In table 1 is shown the effect of NADH on adenylate 
cyclase activity. As seen in the table, basal as well as 
hormone and fluoride-stimulated activity is inhibited 
in a concentration-dependent fashion. NAD added to 
the incubation in 10 mM concentration (table 1) or 
higher does not affect the enzyme activity, which 
2. Materials and methods 
Fat cell membranes were prepared from epididymal 
fat from rats weighing 150-200 g as described by 
Avruch and Wallach [5] as modified by Harwood et 
al. [6] but without addition of mercaptoethanol. 
Adenylate cyclase activity was assayed according to 
Salomon et al. [7]. The incubations were run for 
10 min and the incubation medium contained 25 mM 
Tris-HC1, pH 7.4, 5 mM MgCI2,0.1 mM ATP labelled 
with [32p] ATP 10 mM theophylline and an ATP- 
regenerating system consisting of 25 mM creatinine 
Table 1 
Effect of NADH and NAD on basal and hormone 
activated adenylate cyclase activity 
cAMP, (nmoles/mg prot/10 min) 
Noradrenaline ACTH (1-24) 
(3 #M) (0.3 ~M) 
- 2.3 12.6 6.2 
NADH, 1 mM 1.8 9.1 3.7 
NADH, 3 mM 1.3 4.9 2.9 
NADH, 10 mM 0.9 3.5 1.3 
NAD, 10 mM 1.0 12.8 5.3 
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Table 2 
Effect of NADPH on adenylate cyclase activity 
in adipocyte plasma membranes 
cAMP, (nmoles/mg prot/10 min) 
NADPH Basal Noradrenaline ACTH (1-24) F- 
(mM) (30 #M) (0.3 ~aM) (100 mM) 
1.22 4.64 1.68 1.98 
1 1.17 4.45 1.82 2.10 
3 1.12 4.36 1.61 2.08 
10 1.30 5.71 1.72 2.22 
stresses the fact that the reduced state of the 
nucleotide is of importance for the effect. On the other 
hand NADPH has no such inhibitory effect as seen in 
table 2. On the contrary NADPH tends to stimulate 
the cyclase. NADH inhibition is independent of the 
concentration of hormone added as is seen in table 3. 
Increasing concentrations of noradrenaline ata constant 
concentration of NADH gives the same relative 
inhibition, independent of the hormone concentration. 
If ferricyanide is added to an incubation mixture as 
an oxidizing agent he fluoride stimulated activity 
shows a pronounced stimulation (table 4). The 
inhibitory effect of ferricyanide on the ACTH stimula- 
tion can be related to the inactivation of ACTH by 
oxidizing agents [9]. 
Atebrine, which interferes with the NADH dehydro- 
genase flavin in mitochondria [ 10], inhibits the basal 
adenylate cyclase activity as well as hormone stimulat- 
ed activity but has no effect on the fluoride stimulated 
activity (table 5). Azide, which has recently been 
introduced as a stimulant of adenylate cyclase [11 ], 
Table 3 
Effect of varying noradrenaline concentrations on
the NADH inhibition of adenylate cyclase activity 
cAMP, nmoles/mg prot/10 min 
Noradrenaline NADH Percent 
(uM) - (5 mM) inhibition 
0 4.4 2.0 65 
1 9.1 3.3 65 
3 10.0 5.0 50 
10 13.5 5.8 57 
30 15.5 6.1 61 
Table 4 
Effect of NADH and ferricyanide 
on adenylate cyclase activity 
Additions 
cAMP, nmoles/mg prot/10 min 
ACTH (1-24) F -  
- (0 .3  t~M) (10  raM) 
- 1.8 3.5 7.0 
NADH, 3 mM 1.4 2.2 5.2 
NADH, 10 mM 0.7 1.2 3.4 
Potassium ferri- 
cyanide 10 mM 1.2 1.9 10.2 
gives rise to an activity, which is inhibited by atebrine 
(table 5). This is a further evidence for a difference in 
stimulation mechanism between azide and fluoride. 
The finding that the adenylate cyclase is sensitive 
to the redox state of the environment, opens a new 
line of investigation on the control mechanism of 
hormone activation. The finding that NADH but not 
NADPH or NAD inhibits the system makes it likely 
that the effect is specific and enzyme-mediated and 
not an unspecific redox artefact. Although the NADH 
concentration used might seem to be high, the 
concentration of NADH + NAD which has been 
observed in the cytosol is in the same milimolar ange 
[12]. If the inhibition would be due to, e.g. a lipid 
peroxidation one would rather expect he NADPH to 
be inhibitory. As a control responsive to the metabolic 
state of the cell mediation by NADH seems to be 
ideal. Some biological applications are obvious. An 
example is the high degree of NAD-reduction in 
neoplastic ells, noted by O. Warburg [13] and lately 
shown to be present in virally transformed cells [14], 
Table 5 
Effect of atebrine on adenylate cyclase activity 
Atebrine 
(raM) 
cAMP (nm oles/mg prot/10 min) 
Noradrenaline Fluoride 
(30 uM) (10 mM) 
Azide 
(100 mM) 
- 4 .5  9.2 15.1 
1 2.2 4.6 14.6 
3 0.4 1.5 12.5 
13.5 
9.0 
3.2 
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the reason for the low activity [15] of adenylate cyclase 
of such cells? In such a case the rapid proliferation of 
cells, which seems to be related to a low cyclic AMP 
level, might as Warburg postulated, be initially due to 
an increased NADH/NAD ratio. 
It is also tempting to speculate about the nature of 
the sensor for the NADH. The finding that ferric ions 
tend to stimulate cyclase activity and inhibition of 
cyclase by atebrine might indicate, that the sensor 
might be a redox enzyme system. NADH dehydrogenase 
is known in plasma membranes and preliminary 
studies indicate hormone response in these dehydro- 
genases which may relate to the control of the cyclase 
(F. L. Crane and H. L6w, in preparation). 
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